An elderly person in a COVID clinic

A 90-year-old British grandmother became the first person to receive a fully approved COVID-19 vaccine shot on Tuesday, Reuters reported. 

Last week, the UK became the first country in the world to approve the use of the Pfizer/BioNtech COVID-19 vaccine among its citizens, the BBC reported. According to the report, the priorities include the elderly and staff inside care homes, followed by other elderlies and health staff. 

Margaret Keenan, the first woman to get vaccinated against COVID-19, told Reuters she’s “happy it happened.” 

She also hoped it’ll help people “come along” and do as she did to “get rid” of the virus. 

After Keenan, Britain vaccinated its second patient, a man with a famous name, William Shakespeare. Shakespeare is 81 years old. 

British Health Secretary, Matt Hancock, said he is expecting millions of people to get vaccinated by year’s end. 

In fact, the UK has already ordered supplies from Pfizer/BioNTech enough for 20 million people in the country. 

Despite the vaccine around, Hancock reminded the public to still adhere to the rules of social distancing until at least spring. 

By then, Hancock hopes the UK has already vaccinated most of its vulnerable people.

The coronavirus vaccine from Pfizer

Vaccine Situation in the US…

A vaccine is yet to be approved by the FDA for emergency use. However, Pfizer is the first company in the US to have filed for the emergency use of its vaccine.

Moreover, according to Politico, the US agency seem to back Pfizer’s proposal for its COVID-19 vaccine’s emergency use. 

In fact, on Tuesday, the FDA says Pfizer’s COVID-19 vaccine shot shows “a favorable safety profile,” per briefing documents.  

Also, they found “no specific safety concerns.” 

Politico also reported that US President Donald Trump has ordered the agency to move quicker. The pressure has been building after the UK, and other countries began authorizing the emergency shots of COVID-19 vaccines among the public.

LEAVE A REPLY

Please enter your comment!
Please enter your name here